The role of neuromuscular ultrasound in diagnostics of peripheral neuropathies induced by cytostatic agents or immunotherapies

Abstract A relevant number of cancer patients who receive potentially neurotoxic cytostatic agents develop a chemotherapy-induced peripheral neuropathy over time. Moreover, the increasing use of immunotherapies and targeted agents leads to a raising awareness of treatment-associated peripheral neuro...

Full description

Bibliographic Details
Main Authors: Stefanie Hartinger, Jakob Hammersen, Niklas A. Leistner, Anna Lawson McLean, Clemens Risse, Christian Senft, Stefanie Schütze, Bianka Heiling, Matthias Schwab, Irina Mäurer
Format: Article
Language:English
Published: BMC 2023-11-01
Series:Acta Neuropathologica Communications
Subjects:
Online Access:https://doi.org/10.1186/s40478-023-01685-9
_version_ 1827602567858749440
author Stefanie Hartinger
Jakob Hammersen
Niklas A. Leistner
Anna Lawson McLean
Clemens Risse
Christian Senft
Stefanie Schütze
Bianka Heiling
Matthias Schwab
Irina Mäurer
author_facet Stefanie Hartinger
Jakob Hammersen
Niklas A. Leistner
Anna Lawson McLean
Clemens Risse
Christian Senft
Stefanie Schütze
Bianka Heiling
Matthias Schwab
Irina Mäurer
author_sort Stefanie Hartinger
collection DOAJ
description Abstract A relevant number of cancer patients who receive potentially neurotoxic cytostatic agents develop a chemotherapy-induced peripheral neuropathy over time. Moreover, the increasing use of immunotherapies and targeted agents leads to a raising awareness of treatment-associated peripheral neurotoxicity, e.g., axonal and demyelinating neuropathies such as Guillain–Barré-like syndromes. To date, the differentiation of these phenomena from concurrent neurological co-morbidities or (para-)neoplastic nerve affection as well as their longitudinal monitoring remain challenging. Neuromuscular ultrasound (NMUS) is an established diagnostic tool for peripheral neuropathies. Performed by specialized neurologists, it completes clinical and neurophysiological diagnostics especially in differentiation of axonal and demyelinating neuropathies. No generally approved biomarkers of treatment-induced peripheral neurotoxicity have been established so far. NMUS might significantly extend the repertoire of diagnostic and neuromonitoring methods in this growing patient group in short term. In this article, we present enlargements of the dorsal roots both in cytostatic and in immunotherapy-induced neurotoxicity for the first time. We discuss related literature regarding new integrative applications of NMUS for cancer patients by reference to two representative case studies. Moreover, we demonstrate the integration of NMUS in a diagnostic algorithm for suspected peripheral neurotoxicity independently of a certain cancer treatment regimen emphasizing the emerging potential of NMUS for clinical routine in this interdisciplinary field and prospective clinical trials.
first_indexed 2024-03-09T05:22:16Z
format Article
id doaj.art-80e45cd22138476ab9f96dd6d22de894
institution Directory Open Access Journal
issn 2051-5960
language English
last_indexed 2024-03-09T05:22:16Z
publishDate 2023-11-01
publisher BMC
record_format Article
series Acta Neuropathologica Communications
spelling doaj.art-80e45cd22138476ab9f96dd6d22de8942023-12-03T12:39:54ZengBMCActa Neuropathologica Communications2051-59602023-11-0111111110.1186/s40478-023-01685-9The role of neuromuscular ultrasound in diagnostics of peripheral neuropathies induced by cytostatic agents or immunotherapiesStefanie Hartinger0Jakob Hammersen1Niklas A. Leistner2Anna Lawson McLean3Clemens Risse4Christian Senft5Stefanie Schütze6Bianka Heiling7Matthias Schwab8Irina Mäurer9Department of Neurology, Jena University Hospital, Friedrich Schiller University JenaKlinik für Innere Medizin II, Hämatologie, Internistische Onkologie und Palliativmedizin, Universitätsklinikum Jena, Friedrich-Schiller-Universität JenaDepartment of Neurology, Jena University Hospital, Friedrich Schiller University JenaNeurooncological Center, Jena University Hospital, Friedrich Schiller University JenaDepartment of Neurology, Jena University Hospital, Friedrich Schiller University JenaNeurooncological Center, Jena University Hospital, Friedrich Schiller University JenaDepartment of Gynecology and Reproductive Medicine, Jena University Hospital, Friedrich Schiller University JenaDepartment of Neurology, Jena University Hospital, Friedrich Schiller University JenaDepartment of Neurology, Jena University Hospital, Friedrich Schiller University JenaDepartment of Neurology, Jena University Hospital, Friedrich Schiller University JenaAbstract A relevant number of cancer patients who receive potentially neurotoxic cytostatic agents develop a chemotherapy-induced peripheral neuropathy over time. Moreover, the increasing use of immunotherapies and targeted agents leads to a raising awareness of treatment-associated peripheral neurotoxicity, e.g., axonal and demyelinating neuropathies such as Guillain–Barré-like syndromes. To date, the differentiation of these phenomena from concurrent neurological co-morbidities or (para-)neoplastic nerve affection as well as their longitudinal monitoring remain challenging. Neuromuscular ultrasound (NMUS) is an established diagnostic tool for peripheral neuropathies. Performed by specialized neurologists, it completes clinical and neurophysiological diagnostics especially in differentiation of axonal and demyelinating neuropathies. No generally approved biomarkers of treatment-induced peripheral neurotoxicity have been established so far. NMUS might significantly extend the repertoire of diagnostic and neuromonitoring methods in this growing patient group in short term. In this article, we present enlargements of the dorsal roots both in cytostatic and in immunotherapy-induced neurotoxicity for the first time. We discuss related literature regarding new integrative applications of NMUS for cancer patients by reference to two representative case studies. Moreover, we demonstrate the integration of NMUS in a diagnostic algorithm for suspected peripheral neurotoxicity independently of a certain cancer treatment regimen emphasizing the emerging potential of NMUS for clinical routine in this interdisciplinary field and prospective clinical trials.https://doi.org/10.1186/s40478-023-01685-9Neuromuscular ultrasoundCancerPeripheral neuropathyChemotherapyImmunotherapyNeurotoxicity
spellingShingle Stefanie Hartinger
Jakob Hammersen
Niklas A. Leistner
Anna Lawson McLean
Clemens Risse
Christian Senft
Stefanie Schütze
Bianka Heiling
Matthias Schwab
Irina Mäurer
The role of neuromuscular ultrasound in diagnostics of peripheral neuropathies induced by cytostatic agents or immunotherapies
Acta Neuropathologica Communications
Neuromuscular ultrasound
Cancer
Peripheral neuropathy
Chemotherapy
Immunotherapy
Neurotoxicity
title The role of neuromuscular ultrasound in diagnostics of peripheral neuropathies induced by cytostatic agents or immunotherapies
title_full The role of neuromuscular ultrasound in diagnostics of peripheral neuropathies induced by cytostatic agents or immunotherapies
title_fullStr The role of neuromuscular ultrasound in diagnostics of peripheral neuropathies induced by cytostatic agents or immunotherapies
title_full_unstemmed The role of neuromuscular ultrasound in diagnostics of peripheral neuropathies induced by cytostatic agents or immunotherapies
title_short The role of neuromuscular ultrasound in diagnostics of peripheral neuropathies induced by cytostatic agents or immunotherapies
title_sort role of neuromuscular ultrasound in diagnostics of peripheral neuropathies induced by cytostatic agents or immunotherapies
topic Neuromuscular ultrasound
Cancer
Peripheral neuropathy
Chemotherapy
Immunotherapy
Neurotoxicity
url https://doi.org/10.1186/s40478-023-01685-9
work_keys_str_mv AT stefaniehartinger theroleofneuromuscularultrasoundindiagnosticsofperipheralneuropathiesinducedbycytostaticagentsorimmunotherapies
AT jakobhammersen theroleofneuromuscularultrasoundindiagnosticsofperipheralneuropathiesinducedbycytostaticagentsorimmunotherapies
AT niklasaleistner theroleofneuromuscularultrasoundindiagnosticsofperipheralneuropathiesinducedbycytostaticagentsorimmunotherapies
AT annalawsonmclean theroleofneuromuscularultrasoundindiagnosticsofperipheralneuropathiesinducedbycytostaticagentsorimmunotherapies
AT clemensrisse theroleofneuromuscularultrasoundindiagnosticsofperipheralneuropathiesinducedbycytostaticagentsorimmunotherapies
AT christiansenft theroleofneuromuscularultrasoundindiagnosticsofperipheralneuropathiesinducedbycytostaticagentsorimmunotherapies
AT stefanieschutze theroleofneuromuscularultrasoundindiagnosticsofperipheralneuropathiesinducedbycytostaticagentsorimmunotherapies
AT biankaheiling theroleofneuromuscularultrasoundindiagnosticsofperipheralneuropathiesinducedbycytostaticagentsorimmunotherapies
AT matthiasschwab theroleofneuromuscularultrasoundindiagnosticsofperipheralneuropathiesinducedbycytostaticagentsorimmunotherapies
AT irinamaurer theroleofneuromuscularultrasoundindiagnosticsofperipheralneuropathiesinducedbycytostaticagentsorimmunotherapies
AT stefaniehartinger roleofneuromuscularultrasoundindiagnosticsofperipheralneuropathiesinducedbycytostaticagentsorimmunotherapies
AT jakobhammersen roleofneuromuscularultrasoundindiagnosticsofperipheralneuropathiesinducedbycytostaticagentsorimmunotherapies
AT niklasaleistner roleofneuromuscularultrasoundindiagnosticsofperipheralneuropathiesinducedbycytostaticagentsorimmunotherapies
AT annalawsonmclean roleofneuromuscularultrasoundindiagnosticsofperipheralneuropathiesinducedbycytostaticagentsorimmunotherapies
AT clemensrisse roleofneuromuscularultrasoundindiagnosticsofperipheralneuropathiesinducedbycytostaticagentsorimmunotherapies
AT christiansenft roleofneuromuscularultrasoundindiagnosticsofperipheralneuropathiesinducedbycytostaticagentsorimmunotherapies
AT stefanieschutze roleofneuromuscularultrasoundindiagnosticsofperipheralneuropathiesinducedbycytostaticagentsorimmunotherapies
AT biankaheiling roleofneuromuscularultrasoundindiagnosticsofperipheralneuropathiesinducedbycytostaticagentsorimmunotherapies
AT matthiasschwab roleofneuromuscularultrasoundindiagnosticsofperipheralneuropathiesinducedbycytostaticagentsorimmunotherapies
AT irinamaurer roleofneuromuscularultrasoundindiagnosticsofperipheralneuropathiesinducedbycytostaticagentsorimmunotherapies